SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-008654
Filing Date
2022-03-09
Accepted
2022-03-09 17:17:09
Documents
13
Period of Report
2022-03-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10035009_8k.htm   iXBRL 8-K 52913
  Complete submission text file 0001140361-22-008654.txt   228822

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA adma-20220307.xsd EX-101.SCH 4377
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adma-20220307_def.xml EX-101.DEF 17551
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE adma-20220307_lab.xml EX-101.LAB 27040
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adma-20220307_pre.xml EX-101.PRE 19730
7 EXTRACTED XBRL INSTANCE DOCUMENT brhc10035009_8k_htm.xml XML 5844
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

IRS No.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36728 | Film No.: 22726300
SIC: 2836 Biological Products, (No Diagnostic Substances)